A similar 24-h blood pressure control is obtained by zofenopril and candesartan in primary hypertensive patients

Blood Pressure

Volumn 15, Issue SUPPL. 1, 2006, Pages 18-26

  Leonetti, G ^a,d   Rappelli, A ^b   Omboni, S ^c   Ansuini, R ^e   Acquarone, N ^e   Antonucci, E ^e   Campanini, M ^e   Paracchini, E ^e   Celegon, L ^e   Lazzari, F ^e   Crippa, M ^e   Caruso, D ^e   D'Avino, M ^e   Di Biase, M ^e   Manuppelli, V ^e   Pellegrino, P L ^e   Etna, N ^e   Fiorentini, C ^e   Lucreziotti, S ^e   Galetta, F ^e   Franzoni, F ^e   Femia, R ^e   Giovannetti, R ^e   Auteri, A ^e   Bruni, F ^e   Leo, A ^e   Lonati, L ^e   Magnaghi, G C ^e   Sensale, P ^e   Maiolica, O ^e   Malinverni, C ^e   Mangiameli, S ^e   Cardillo, R ^e   Antonelli, A ^e   Mazzotta, L ^e   Nami, R ^e   Salvo, D P ^e   Pezzotti, U ^e   Monti, G ^e   Novati, P ^e   Furlan, R ^e   Perego, F ^e   Pede, S ^e   Pico, C ^e   Renna, A ^e   Margonato, A ^e   Pizzetti, R ^e   Prinzi, D ^e   Smimmo, D ^e   De Cicco, G ^e   Napolitano, G ^e   Reynaud, M ^e   Piccoli, M ^e   Cipollari, G ^e   Sacca P L ^e   Oliviero, U ^e   Ettari, E L ^e   Scanferla, F ^e   Rosato, G ^e   Siano, F ^e   Cianciucci, G M ^e   Pagliuca, M R ^e   Santucci, A ^e   Ferri, C ^e   Desideri, G B ^e   Zingaretti, O ^e   more..

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale Regionale Torrette   (Italy)

^c Data Management Unit   (Italy)

^d Ospedale San Luca   (Italy)

^e NONE

Author keywords

Ambulatory blood pressure monitoring; Candesartan; Primary hypertension; Smoothness index; Trough to peak ratio; Zofenopril

Indexed keywords

CANDESARTAN; ZOFENOPRIL;

ADULT; ANKLE EDEMA; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASTHENIA; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 33644807507     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08038020510046689     Document Type: Article

References (32)

1. Guidelines Subcommittee of the World Health Organization-International Society of Hypertension (WHO-ISH) Mild Hypertension Liaison Committee. (1999) World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens, 17, pp. 151 - 183.
2. Chobanian, A. V. and Bakris, G. L. and Black, H. R. and Cushman, W. C. and Green, L. A. and Izzo, J. L. and (2003) and the National High Blood Pressure Education Program Coordinating Committee The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). JAMA, 289, pp. 2560 - 2572.
3. Guidelines Committee. (2003) European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 21, pp. 1011 - 1053.
4. Borghi, C. and Ambrosioni, E. and Survival of Myocardial Infarction Long-term Evaluation-2 Working Party.Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. Am Heart J, 145, pp. 80 - 87.
5. Borghi, C. and Bacchelli, S. and Esposti, D. D. and Bignamini, A. and Magnani, B. and Ambrosioni, E. (1999) Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. Am J Hypertens, 12, pp. 665 - 672.
6. Borghi, C. and Bacchelli, S. and Esposti, D. D. and Ambrosioni, E. and SMILE Study.Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction. Diabetes Care, 26, pp. 1862 - 1868.
7. Kelbaek, H. and Agner, E. and Wroblewski, H. and Vasehus Madsen, P. and Marving, J. (1993) Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure. Eur Heart J, 14, pp. 692 - 695.
8. Binkley, P. F. and Haas, G. J. and Starling, R. C. and Nunziata, E. and Hatton, P. A. and Leier, C. V. and (1993) Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol, 21, pp. 655 - 661.
9. Elijovich, F. and Laffer, C. L. and Schiffrin, E. L. (1997) The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients. J Hum Hypertens, 11, pp. 313 - 319.
10. Lacourciere, Y. and Provencher, P. (1989) Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension. Br J Clin Pharmacol, 27, pp. 371 - 376.
11. Malacco, E. and Piazza, S. and Omboni, S. (2005) Zofenopril versus lisinopril in the treatment of essential hypertension in elderly patients. A randomised, double-blind, multicentre study. Clin Drug Invest, 25, pp. 175 - 182.
12. McClellan, K. J. and Goa, K. L. (1998) Candesartan cilexetil. A review of its use in essential hypertension. Drugs, 56, pp. 847 - 869.
13. O'Brien, E. and Pickering, T. and Asmar, R. and Myers, M. and Parati, G. and Staessen, J. and (2002) Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit, 7, pp. 3 - 17.
14. Parati, G. and Bosi, S. and Castellano, M. and Cristofari, M. and Di Rienzo, M. and Germanò, G. and (1995) Guidelines for 24h non-invasive ambulatory blood pressure monitoring. Report from a working group of the Italian Society of Hypertension. High Blood Press, 4, pp. 168 - 174.
15. Omboni, S. and Parati, G. and Zanchetti, A. and Mancia, G. (1995) Calculation of trough:pEak ratio of antihypertensive treatment from ambulatory blood pressure: Methodological aspects. J Hypertens, 13, pp. 1105 - 1112.
16. Rizzoni, D. and Castellano, M. and Muiesan, M. L. and Porteri, E. and Agabiti-Rosei, E. (1997) Beyond trough:pEak ratio: A new index of the smoothness of the antihypertensive effect of a drug. High Blood Press, 6, pp. 110 - 115.
17. Parati, G. and Omboni, S. and Rizzoni, D. and Agabiti-Rosei, E. and Mancia, G. (1998) The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens, 16, pp. 1685 - 1691.
18. Omboni, S. and Parati, G. and Mancia, G. (1998) The trough:pEak ratio and the smoothness index in the evaluation of control of 24h blood pressure by treatment in hypertension. Blood Press Monit, 3, pp. 201 - 204.
19. Lipicky, R. J. (1994) Trough:pEak ratio: The rationale behind the United States Food and Drug Administration recommendations. J Hypertens, 12(Suppl 8), pp. S17 - S19.
20. Himmelmann, A. and Keinanen-Kiukaanniemi, S. and Wester, A. and Redon, J. and Asmar, R. and Hedner, T. and Effect Study Group.The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension. Blood Press, 10, pp. 43 - 51.
21. Asmar, R. and Lacourciere, Y. and Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators.A new approach to assessing antihypertensive therapy: Effect of treatment on pulse pressure. J Hypertens, 18, pp. 1683 - 1690.
22. Lacourciere, Y. and Asmar, R. (1999) A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: A placebo-controlled, forced titration study. Candesartan/Losartan study investigators. Am J Hypertens, 12((Pt 1-2)), pp. 1181 - 1187.
23. Stergiou, G. S. and Efstathiou, S. P. and Skeva, I. I. and Baibas, N. M. and Roussias, L. G. and Mountokalakis, T. D. (2003) Comparison of the smoothness index, theVtrough:pEak ratio and the morning:evening ratio in assessing the features of the antihypertensive drug effect. Hypertens, 21, pp. 913 - 920.
24. Mancia, G. and Omboni, S. and Parati, G. and Investigators of the INSIGHT ABPM substudy.Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens, 20, pp. 545 - 553.
25. Mancia, G. and Omboni, S. and Parati, G. and Clement, D. L. and Haley, W. E. and Rahman, S. N. and (2001) Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. Hypertens, 19, pp. 1755 - 1763.
26. Omboni, S. and Fogari, R. and Palatini, P. and Rappelli, A. and Mancia, G. (1998) Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: Evidence from the sample study. Hypertension, 32, pp. 424 - 429.
27. Benetos, A. and Rudnichi, A. and Safar, M. and Guize, L. (1998) Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension, 32, pp. 560 - 564.
28. Millar, J. A. and Lever, A. F. and Burke, V. (1999) Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens, 17, pp. 1065 - 1072.
29. Kannel, W. B. and Kannel, C. and Paffenbarger, R. S Jr. and Cupples, L. A. (1987) Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J, 6, pp. 1489 - 1494.
30. Mancia, G. and Omboni, S. and Parati, G. and Ravogli, A. and Villani, A. and Zanchetti, A. (1995) Lack of placebo effect on ambulatory blood pressure. Am J Hypertens, 8, pp. 311 - 315.
31. Dupont, A. G. and van der Niepen, P. and Six, R. O. (1987) Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol, 24, pp. 106 - 109.
32. Trazzi, S. and Mutti, E. and Frattola, A. and Imholz, B. and Parati, G. and Mancia, G. (1991) Reproducibility of non-invasive and intra-arterial blood pressure monitoring: Implications for studies on antihypertensive treatment. J Hypertens, 9, pp. 115 - 119.